Artificial cannabinoids were being designed for cannabinoid research specializing in tetrahydrocannabinol (THC), cannabinoid receptors, as well as endocannabinoids that activate them in the body. Synthetic cannabinoids were being necessary partly resulting from legal constraints on normal cannabinoids, which make them tough to get for investigation